Case Discussion on Management of Infantile Epilepsy

Infantile epilepsy, also known as early onset epilepsy, is a type of epilepsy that starts in the first two years of life. It is characterized by seizures that may be subtle, such as staring spells, or more obvious, such as convulsions. The causes of infantile epilepsy are varied and may be due to genetic factors, brain malformations, or brain injuries. The management of infantile epilepsy involves a comprehensive approach that focuses on controlling seizures, minimizing side effects of medications, and improving the quality of life of the child and their family. Treatment typically involves the use of antiepileptic drugs, which are selected based on the type of epilepsy and the age of the child.

Clinical Communication Skills for Pediatrician

Case Discussion on Hematuria in Children

In children, the causes of hematuria can range from simple infections to serious diseases such as kidney disorders or tumors. The color of the urine may vary from pink to red to brown, depending on the amount and type of blood present. Common causes of hematuria in children include urinary tract infections, bladder or kidney stones, and trauma to the urinary tract. Diagnostic tests for hematuria in children may include a physical examination, urine analysis, and imaging studies such as X-rays or ultrasound. Treatment for hematuria will depend on the underlying cause and may include antibiotics, surgery, or medication to manage associated symptoms.

Case Discussion on Neonatal Jaundice

Neonatal jaundice is characterized clinically by a yellowish discoloration of the skin, sclera, and mucous membrane and is caused by high total serum bilirubin (TSB). Unconjugated bilirubin's negative effects on the central nervous system are particularly dangerous for preterm infants and those born with congenital enzyme impairments. If left untreated, severe hyperbilirubinemia may produce acute and chronic bilirubin encephalopathy and bilirubin-induced neurological impairment.

Hemorrhagic Disease of the NewBorn

Hemorrhagic disease of the newborn is a life-threatening condition that is due to insufficient vitamin K levels in newborns as a result of various causes. Proper management of the disease can help reduce disease incidence. This activity outlines the evaluation and treatment of hemorrhagic disease of the newborn and explains the role of the interprofessional team in managing patients with this condition.